Skip to main content
. 2020 May 24;12(5):477. doi: 10.3390/pharmaceutics12050477

Figure 2.

Figure 2

Photomicrographs (A) showing the significant ameliorative effect of C. vitellina extract on HPBL viability, 24 h against MMC toxicity, using acridine orange/ethidium bromide (AO/EB) dual fluorescent staining (Olympus BX 41 fluorescent microscope, Tokyo, Japan). Significant differences at (p ≤ 0.05) with respect to untreated and MMC-treated groups are (a) and (b), respectively. Data were represented as (Mean ± SD) of three different experiments (n = 3), (B). MMC: Mitomycin C (0.5 µg/mL).